BioRestorative Therapies (BRTX) EPS (Basic) (2010 - 2025)
BioRestorative Therapies' (BRTX) quarterly EPS (Basic) came in at -$8.51 in Q4 2025, down 22.76% on a YoY basis from -$11.01 in Q4 2024, and down 4.55% quarter-over-quarter from -$8.14 in Q3 2025.
Powered by 
Analysis
BioRestorative Therapies (BRTX) EPS (Basic) (2010 - 2025) Analysis & Trends
BioRestorative Therapies (BRTX) has reported EPS (Basic) for 16 consecutive years, with -$8.51 the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, EPS (Basic) fell 22.76% year-over-year to -$8.51; the trailing twelve-month figure through Dec 2025 stood at -$34.8 (down 16.9% YoY), and the FY2025 full-year result was -$34.8, down 16.9% from the prior year.
- EPS (Basic) retreated to -$8.51 in Q4 2025 per BRTX's latest filing, from -$8.14 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.02 in Q2 2021 and bottomed at -$99.78 in Q3 2021.
- Historically, EPS (Basic) has averaged -$20.78 across 5 years, with a median of -$12.95 in 2023.
- The sharpest annual moves came in 2021 and 2022: EPS (Basic) slumped 1277788.17% in 2021, then soared 74.47% in 2022.
- Over 5 years, EPS (Basic) stood at -$67.51 in 2021, then soared by 61.66% to -$25.88 in 2022, then soared by 41.0% to -$15.27 in 2023, then surged by 54.62% to -$6.93 in 2024, then declined by 22.76% to -$8.51 in 2025.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$8.51, -$8.14, and -$7.56 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.26 Bn | 9.41 Bn | 112.79 Mn | 1.85 |
| 2 | CRISPR Therapeutics AG | 5.02 Bn | 5.02 Bn | - | -0.94 |
| 3 | Iovance Biotherapeutics | 3.73 Bn | 3.44 Bn | 55.72 Mn | -0.11 |
| 4 | Legend Biotech | 3.62 Bn | 2.66 Bn | 251.50 Mn | 0.42 |
| 5 | uniQure | 2.99 Bn | 2.99 Bn | 5.49 Mn | -1.22 |
| 6 | Beam Therapeutics | 2.52 Bn | 2.52 Bn | - | -1.18 |
| 7 | Precigen | 2.36 Bn | 2.36 Bn | 52.17 Mn | 0.06 |
| 8 | Sarepta Therapeutics | 2.25 Bn | 1.46 Bn | 251.87 Mn | -0.05 |
| 9 | Vericel | 1.96 Bn | 1.80 Bn | 56.40 Mn | 0.04 |
| 10 | BioRestorative Therapies | 1.27 Mn | -1.69 Mn | 17,964.00 | -8.51 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -8.51 |
| Sep 30, 2025 | -8.14 |
| Jun 30, 2025 | -7.56 |
| Mar 31, 2025 | -11.51 |
| Dec 31, 2024 | -6.93 |
| Sep 30, 2024 | -5.63 |
| Jun 30, 2024 | -6.08 |
| Mar 31, 2024 | -12.32 |
| Dec 31, 2023 | -15.27 |
| Sep 30, 2023 | -13.58 |
| Jun 30, 2023 | -16.04 |
| Mar 31, 2023 | -31.09 |
| Dec 31, 2022 | -25.88 |
| Sep 30, 2022 | -25.47 |
| Jun 30, 2022 | -25.44 |
| Mar 31, 2022 | -28.69 |
| Dec 31, 2021 | -67.51 |
| Sep 30, 2021 | -99.78 |
| Jun 30, 2021 | -0.02 |
| Mar 31, 2021 | -0.10 |